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Abstract
Background: Disadvantaged communities suffer higher levels of physical and mental ill health than
more advantaged communities. The purpose of the present study was to examine the psychosocial,
behavioural and biological determinants of ill health within population groups in Glasgow that
differed in socioeconomic status and in their propensity to develop chronic disease especially
coronary heart disease and Type 2 diabetes mellitus.
Methods: Participants were selected at random from areas known to be at the extremes of the
socioeconomic continuum in Glasgow. Within the categories of least deprived and most deprived,
recruitment was stratified by sex and age to achieve an overall sample containing approximately
equal numbers of males and females and an even distribution across the age categories 35–44, 45–
54 and 55–64 years. Individuals were invited by letter to attend for assessment of their medical
history, risk factor status, cognitive function and psychological profile, morbidity, and carotid
intima-media thickness and plaque count as indices of atherosclerosis. Anonymised data on study
subjects were collected from the General Practice Administration System for Scotland to analyse
characteristics of participants and non-participants.
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BMC Public Health 2008, 8:126 http://www.biomedcentral.com/1471-2458/8/126Results: 700 subjects were recruited. The response (active participants per 100 invitation letters)
in the least deprived group was 35.1% and in the most deprived group was 20.3%. Lowest response
was seen in young males (least deprived 22.4% and most deprived 14.1%).
Conclusion: This cross-sectional study recruited the planned sample of subjects from least
deprived and most deprived areas within Glasgow. As evident in other studies response differed
between the most and least deprived areas. This study brought together researchers/academics
from diverse disciplines to build a more sophisticated understanding of the determinants of health
inequalities than can be achieved through unidisciplinary approaches. Future analyses will enable an
understanding of the relationships between the different types of measure, and of the pathways that
link poverty, biology, behaviour and psychology and lead to health inequalities.
Background
Heart disease, diabetes, some cancers, rheumatoid arthri-
tis and mental illness are examples of the burden of ill-
health that is carried disproportionately by deprived com-
munities[1]. Not only is the prevalence and incidence of
disease higher in areas of deprivation but also the nature
of the problem appears to be qualitatively different, and
treatment less successful[2]. This inequality in disease risk
can partially be explained by the higher prevalence of clas-
sical risk factors in deprived areas, but this explanation
fails to account for the totality of the variations [3-5].
There are social gradients in a range of biological and psy-
chosocial variables which indicate that living in a
deprived environment may increase the propensity to
develop chronic disease, through as yet unknown mecha-
nisms[6,7]. A potential underlying cause of increased
prevalence of disease is chronic inflammation. This has
been observed to be more common in deprived than
affluent populations, [8-12] linked to coronary heart dis-
ease[13,14], increased risk of type 2 diabetes[15,16] and
other disorders[17], as well as cognitive dysfunction and
altered psychological profile [18-21]. Atherosclerosis is
now understood to be an inflammatory disorder with key
components of the innate immune system being inti-
mately involved in the initiation and progression of
plaques on the artery wall, and in triggering an acute cor-
onary event such as myocardial infarction[14]. The aetiol-
ogy of diabetes appears also to involve activation of innate
immunity with high levels of inflammatory biomarkers
such as C reactive protein being associated with increased
risk of developing the disorder[15]. Because of the aetio-
logical links, some suggest that coronary heart disease and
type 2 diabetes arise from a 'common soil'[22].
The cause of increased activation of the innate immune
system in individuals from deprived populations is not
clear. It may be linked to poor living and working condi-
tions such as exposure to pathogens, or to increased levels
of obesity. There is abundant evidence linking the accu-
mulation of abdominal fat to raised levels of inflamma-
tory cytokines in the plasma[23,24]. Further it is
noteworthy that the relationship between body fat and
inflammation is present even in children[25] suggesting
that propensity to some adult chronic diseases may begin
early in life. Abdominal obesity is believed to be a major
precipitating factor in the development of insulin resist-
ance and ultimately in the development of type diabe-
tes[26]. For this reason the present 'epidemic' of obesity in
many countries around the world is a significant concern
for public health authorities and healthcare providers.
Chronic inflammation, central obesity and insulin resist-
ance have been associated in population surveys and in
experimental studies with impaired cognitive function
and with an altered (negative) mental outlook. Depres-
sion appears to be more frequent in overweight individu-
als[27,28] and type 2 diabetes is recognised increasingly
as a risk factor for accelerated cognitive decline in the eld-
erly[29,30]. Prospective studies have shown inflamma-
tory markers to predict cognitive decline in initially-
healthy elderly subjects over follow-ups of between one
and ten years[19,30], and that those of lower socio-eco-
nomic status and poorer educational attainment are more
vulnerable to such inflammation-related decline[31].
Recently investigators have reported that a further feature
of central obesity/metabolic syndrome is an altered men-
tal state associated with depression and "loss of con-
trol"[31,32]. It has also been recognised that depression is
commonly found in subjects with CHD and is an impor-
tant factor to overcome as part of recovery from a myocar-
dial infarction [33-35].
These aetiological links need further exploration as poten-
tial explanations of the burden of physical and mental ill
health in deprived communities. From a public health
perspective it is important to establish if those who need
to take on board messages advocating lifestyle change
(weight loss, physical activity) are in a position affectively
and intellectually to receive them. Equally, certain person-
ality and other individual difference factors modify
responses to stress and challenge, conferring both vulner-
ability and protection, and must be accounted for as mod-
erating variables.Page 2 of 11
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BMC Public Health 2008, 8:126 http://www.biomedcentral.com/1471-2458/8/126Glasgow is a particularly appropriate setting for a study of
the effects of deprivation on ill-health because of the
strong socioeconomic gradient within the conurbation,
the fact that deprived communities make up a substantial
proportion of the population and the associated variation
in mortality and morbidity[7]. The present study is to
determine the extent to which the syndrome of central
obesity/chronic inflammation explains the socioeco-
nomic gradient in vascular disease and whether the syn-
drome is associated with alterations in the mental state.
Methods
Aims and Hypotheses
The study for the most part was an exploratory pilot for a
large scale investigation of the genotypic and phenotypic
determinants of ill health in deprived communities The
overall aim was to determine the extent to which the
linked syndrome of central obesity/chronic inflammation
explains the social gradient in vascular disease and
whether the syndrome is associated with alterations in the
mental state.
The hypotheses to be tested were summarised as follows
in the study protocol:
"Socioeconomic gradients in health are influenced by
adverse environmental conditions, work, relationships,
community, knowledge and practice of health-promoting
or health-damaging behaviours. Hormonal and meta-
bolic responses to the above stressors, while protective in
the short term, in the long term causes adverse changes
(e.g. hyperplasia of visceral adipose tissue and central
obesity) that leads to chronic disease (e.g. atherosclero-
sis). Further consequences are a heightened response to
stress and a tendency towards depression and altered
mental function".
Research questions
The following questions were addressed:
1) Do deprived sections of the community display
increased prevalence of features of a condition termed
metabolic syndrome (i.e. central obesity and insulin
resistance) and chronic inflammation compared to afflu-
ent sections?
2) Do deprived groups exhibit higher levels of serum
endotoxin, revealing increased exposure to bacterial path-
ogens (as a result for example of damp housing) com-
pared to affluent groups?
3) Do deprived groups differ from affluent ones in psy-
chological profile (affective state and cognition) and to
what extent can this be related to the presence of the cen-
tral obesity/insulin resistance/chronic inflammation syn-
drome?
4) Is sub-clinical atherosclerosis (as detected by carotid
ultrasound analysis) more prevalent in deprived groups?
To what extent is the prevalence explained by classical risk
factors (smoking, blood pressure, cholesterol) and to
what extent is it related to the presence of metabolic syn-
drome?
In addition, we sought to ascertain the feasibility of a large
scale population study by determining response rate, drop
out rate, time taken by respondents to complete the ques-
tionnaires and the visits, any discomfort experienced by
respondents to the various medical assessments, numbers
volunteering for the Magnetic Resonance Imaging (MRI)
Scan etc, and how the above were affected by age group,
sex and deprivation category.
Ethical approval and confidentiality
Ethical approval for the study was obtained from Glasgow
Royal Infirmary Research Ethics committee. In all study
records (electronic and paper) subjects were identified
only by their study number. Information linking identity
(name, address, general practitioners) to study number
was held securely by the Glasgow Centre for Population
Health[36] (GCPH; the coordinating centre). Only ano-
nymised data were obtained from General Practice
Administration System for Scotland[37] (GPASS) records
on practice computers. The Health Board's Caldicott
Guardian approved the study process and GPs with the
approval of the ethics committee consented to the use of
Community Health Index[38] and anonymised GPASS
data.
The Health Information and Technology (HIT) section of
the Greater Glasgow Health Board (GGHB) was responsi-
ble for sample selection and assignment of a study
number to each subject (from 0001 to 3,600).
Subjects
Selection was based on the Scottish Index for Multiple
Deprivation[39] (SIMD) which identified the least and
most deprived areas in the Glasgow conurbation area.
Five general practitioners (GP) practices with the highest
percentage of patients aged 35–64 years living in areas
classified as being in the bottom 5% of SIMD [most
deprived (MD)] were approached and all agreed to partic-
ipate in the recruitment process. A further five practices
with the highest percentage of patients aged 35–64 years
living in areas classified as being in the top 20% of SIMD
[least deprived (LD)] also agreed to participate.
HIT generated a target population of 21,672 people from
the GP lists of these ten practices (Table 1). From this tar-Page 3 of 11
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according to strata defined by the combination of cate-
gory, sex and age-group (35 to 44, 45 to 54, and 55 to 64
years) (Table 1) giving a total sampling frame of 3,600
subjects. As the study progressed, over-sampling of sub-
jects from the most deprived group was required (due to
the lower response rate) and the HIT section was
approached to select randomly further potential subjects
from the target population. GPs were able to exclude per-
sons from the sample who had recently expired or who
had a terminal illness. Due to the nature of the psycholog-
ical questionnaires and cognitive assessment, only those
who understood and spoke English were invited to partic-
ipate in this pilot study. The eligibility of subjects was
checked by GPs and Practice Managers before letters were
sent.
If the participant had had an illness which was likely to
increase CRP levels acutely (e.g. urinary tract infection,
upper respiratory tract infection, etc.) during the two
weeks prior to his/her appointment this was recorded but
assessments proceeded on the scheduled date.
Recruitment Procedure
Invitation letters to selected subjects were sent in batches
of 150 every two weeks. Accompanying the letter was a
form for the subject to return (in a reply paid envelope)
recording their contact details and indicating their will-
ingness to consider participation. Subjects who agreed to
receive further information about the study were sent the
pSoBid participant information booklet[40]. If there was
no response after two weeks, a reminder was sent. The
Research Nurse contacted those who received the partici-
pant information booklet, and if after reading the infor-
mation booklet they decided to participate in the study,
they were invited to come for the first visit at their GP's
clinic on a mutually agreed day and time (see Additional
file 1 for flowchart). This process continued until approx-
imately equal numbers for the 12 groups were recruited.
Protocol
The study comprised two visits, each lasting about an
hour and a half to two hours. Arrangements were made
for taxi transfers to and from the participants' homes.
Posters advertising the study were displayed in GP Clinics
and also in local community centres and libraries. Two
free telephone numbers were set up one in the coordinat-
ing centre and one in the Glasgow Royal Infirmary (GRI)
where the research nurses were based.
At Visit 1 the study was explained to participants and
informed consent obtained. The visit involved comple-
tion of lifestyle and psychology questionnaires, assess-
ment of health status and measurement of blood pressure,
pulse rate and indices of obesity (height, weight, hip,
waist and mid thigh circumference). Lung function was
measured by Forced Expiratory Volume in one second
(FEV1) and Forced Vital Capacity (FVC). Questionnaires
completed at this visit examined affective state and con-
trol/coping i.e. the General Health Questionnaire[41]
(which has been used previously in this context by other
research groups[31,42]), the Generalised Self-Efficacy
Scale[43], the Sense of Coherence Scale[44] and Beck
Hopelessness Scale[45]. An appointment was made for
the second visit (in the morning and fasting) to be carried
out at GRI on a date convenient to the participant.
At Visit 2, a fasting blood sample was taken to measure
cholesterol, triglycerides, very low density lipoprotein
(VLDL), low density lipoprotein (LDL) and high density
lipoprotein (HDL), markers of diabetes and obesity (glu-
cose, insulin, leptin and adiponectin), markers of inflam-
mation and clotting [C-reactive protein (CRP);
inerleukin-6, (IL6); fibrinogen, D dimer; tissue plasmino-
gen activator (tPA) antigen], and markers of endothelial
dysfunction [Intercellular Adhesion Molecule (ICAM);
von Willebrand Factor (vWF)]. Then, after breakfast, par-
ticipants completed further psychological and cognitive
function tests, and underwent ultrasound assessment of
carotid intima media thickness and plaque count. Previ-
ous research has shown an association between eating
breakfast and mood and performance, with the effects due
in part to experimental manipulation of the normal
morning routine[46,47]. In this study as far as possible
breakfast was provided according to an individual's nor-
mal routine (or abstinence, if relevant), so that any effects
Table 1: pSoBid target population by age and sex identified SIMD 2004
Males Females Both Sexes
Number of subjects living in: 35–44 years 45–54 years 55–64 years Total 35–44 years 45–54 years 55–64 years Total 35–64 yrs
20% Least Deprived area* 2,124 2,169 2,024 6,317 2,278 2,335 2,074 6,687 13,004
5 % Most Deprived area* 1,931 1,482 949 4,362 1,849 1,366 1,091 4,306 8,668
Total 4,055 3,651 2,973 10,679 4,127 3,701 3,165 10,993 21,672
* The most deprived sample was drawn from the category 5% most deprived by SIMD. The least deprived sample was drawn from subjects living in 
areas classed by SIMD as in the 20% least deprived categoryPage 4 of 11
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observed in real life.
Psychology questionnaires completed by the participants
at Visit 2 provided indices of personality and individual
differences in self-esteem. The personality factor of neu-
roticism is known significantly to affect emotional
responsiveness and adjustment. Assessment involved self-
completion of the Eysenck Personality Scales[48] and the
Rosenberg Self-Esteem Scale[49]. Cognitive assessment
involved the following main domains of cognition: exec-
utive function (tested by Trails Test[50] and Stroop
Test[51]), memory (tested by Auditory Verbal Learning
Test) and cognitive performance (estimated from the
NART-2[52] which provided a proxy measure of "IQ").
Attention and speed of processing were tested by Choice
Reaction Time[53].
Male participants were asked if they would be interested in
participating in MRI scanning (Visit 3). From a total of 327
male participants, 140 volunteered, and 40 of these were
randomly selected (stratified by age group and deprivation
category). These scans will be completed by spring 2008.
Before each visit the participants were contacted by tele-
phone on the previous day to confirm their attendance
and to ensure that the taxi arrangements were in place. At
the end of the study all participants were sent a letter
thanking them for their participation in the study and
were informed that they would all receive an executive
summary of the study findings. After each visit partici-
pants were asked to complete a feedback form detailing
their opinion of the study and their experiences.
Lifestyle questionnaire
This questionnaire had 13 sections including basic demo-
graphic data, past and present health status, current med-
ications, oral health, smoking history, alcohol intake,
diet, physical activity levels, childhood situation, birth
weight and place of birth, their parents' age and father's
occupation, education levels, employment history and
income levels.
Carotid intima media thickness
Measurement of the intima media thickness of the carotid
artery by high resolution ultrasound is now a widely
accepted, non-invasive, surrogate measure of atheroscle-
rosis and a reliable indicator of future risk of a major cor-
onary event[54,55]. Carotid intima media thickness
provides a suitable continuous outcome measure for
atherosclerosis, enabling association studies to be per-
formed on fewer numbers (i.e. hundreds of subjects com-
pared to classical surveys using endpoints such as MI
which require sample sizes in the thousands). Recent
carotid intima media thickness studies have evaluated the
extent to which sex differences in CHD are explained by
central obesity, the relationship between degree of athero-
sclerosis (intima media thickness) and inflammation sta-
tus (CRP levels)[55,56] and the relationship of
periodontal disease to carotid intima media thick-
ness[57]. Ultrasound examination of the carotid arteries
also allows presence and number of plaques to be deter-
mined[58,59]. Carotid plaque count has previously been
found to be a predictor of myocardial infarction[58] and
stroke[60]. The carotid ultrasound examination lasted 20
to 30 minutes. Doppler velocity in right and left internal
carotid arteries was recorded in order to identify any sig-
nificant internal carotid artery stenosis. Images of the dis-
tal 1 cm of the common carotid artery, the carotid bulb
and the proximal internal carotid artery were recorded on
the left and right side, and intima-media thickness of the
far wall of the artery determined using the software pack-
age Etrack. The number of carotid plaques at each of the
six sites was determined using published procedures[58].
M-mode ultrasound of the distal common carotid artery
was recorded to assess arterial stiffness. Reading of the
scans was performed off-line by a reader who was blinded
to the identity of the participants.
Recruitment flowchart for the pSoBid studyFigure 1
Recruitment flowchart for the pSoBid study. LD = 
Least Deprived; MD = Most Deprived. M = Male; F = Female.
Number of subjects contacted 
for the study = 2,936 
Number of subjects not 
contactable = 224 
Number of subjects invited to 
participate in the study = 2,712 
Number who 
completed Visit 
1 & Visit 2 = 
666 (95.1%)
Number who 
ONLY 
completed Visit 
1 = 34 (4.9%) 
Target Population = 21,672 (LD = 
13,004; MD = 8,668) ref to Table 
1 for breakdown by age & sex
Random selection from 
target population of 300 
each for 12 groups =  
2 (LD &MD)  
x 2 (M & F)  
x 3 (35-44, 45-54 & 55-
64 yrs) = 3,600 
Number who 
attended Visit 1 = 
700 (25.8%) 
Number who 
declined = 812 
(29.9%) 
Number who did 
not respond = 1,200
(44.3%)
LD = least deprived 
MD = most deprived
M = Male 
F = Female 
224 Letters were returned as 
subject had moved or was not 
known at the address. 
LD = 49 (F=12,M=37),  
MD = 175 (F=39, M=136)
Not all subjects in the LD 
group were invited (as targets 
were met) but in the MD group 
extra numbers were generated 
to meet the targets 
Participants withdrew 
after Visit 1 due to 
other commitments. 
LD = 12 (F=7, M=5) 
MD = 22 (F=13, M=9)
See Figure 2 for breakdown by age, sex and deprivation) 
103 subjects were excluded 
by the GPs as unsuitable for 
taking part in the study. 
LD = 20 (M=5, F=15) 
MD = 83 (M=48, F=35)Page 5 of 11
(page number not for citation purposes)
BMC Public Health 2008, 8:126 http://www.biomedcentral.com/1471-2458/8/126GPASS Extraction Process
GPASS was used to evaluate the characteristics of those
who were invited to participate in the study. Eight of the
ten GP practices (four in the LD area, four in the MD area)
selected for the study use GPASS to record their routine
data. Anonymised data were collected on smoking status
and current prescription for statins, aspirin, antihyperten-
sives, antidepressants and anti-diabetic drugs as evidence
of the prevalence of chronic disease. Data were collected
separately for those who attended visit 1 (Group 1), those
who declined to attend (Group 2) and non-respondents
to the invitation (Group 3). Non-participants (Group 4)
were defined as the combination of groups 2 and 3.
Statistical analysis
Sample size in the LD and MD groups was estimated on
the assumption that 90% would attend both visits and
have CRP measured and that a maximum of 10% would
not have good quality intima media thickness measure-
ments. The power calculations were based on perceived
clinically meaningful differences and assumed a 1.1 mg/L
standard deviation for the natural logarithm of CRP meas-
urements[61] and a 0.163 mm standard deviation for
carotid intima media thickness[62]. Power calculations
indicated that a sample size of 350 per group would pro-
vide 84% power to detect a 30% difference in mean CRP
levels and 82% power to detect a 0.04 mm difference in
mean carotid intima media thickness.
Categorical data are presented as counts and where appro-
priate as percentages. Where formal comparisons of per-
centages have been carried out, chi-squared tests have
been used.
Results
From the sampling frame of 3600 subjects a total of 2,712
invitations were issued to recruit a cohort of 700 (25.8%)
participants. Out of the 2,712 invitations sent, 812
Basic characteristics of subjects included in the pSoBid study by deprivation, sex and ageFigure 2
Basic characteristics of subjects included in the pSoBid study by deprivation, sex and age. * = Included in these % 
are 34 participants who ONLY completed Visit 1.
Deprivation Sex Age Groups % Attended Visit 1* Declined Non- Respondent
22.4% 30.7% 47.9% 35-44 yrs = 241 
35.3% 30.6% 34.1% 45-54 yrs = 167 
   
  
Males = 527 
52.9% 26.1% 21.0%55-64 yrs = 119 
31.5% 36.5% 32.0%
  Least Deprived 1,008 
35-44 yrs = 181 
33.7% 41.6% 24.7%
Females = 481 45-54 yrs = 178
50.0% 37.7% 12.3%55-64 yrs = 122 
14.1% 15.5% 70.4%35-44 yrs = 361 
Total 
Invited 
= 2,712 
17.8% 24.6% 57.6%45-54 yrs = 321 Males = 962 
20.4% 41.1% 38.5%
55-64 yrs = 280
19.2% 22.0% 58.8%
    Most Deprived  
      1,704 35-44 yrs = 318 
28.4% 32.7% 38.9%Females = 742 45-54 yrs = 211 
55-64 yrs = 213 
28.2%
38.0% 33.8% Page 6 of 11
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(44.3%) did not respond (Figure 1). Data collection was
completed in April 2007 and data quality was tested over
the summer of 2007. For calculation of response rate the
denominator used was the total number invited to partic-
ipate in the study.
There were 224 people in the sample who were not con-
tactable. Letters were returned by the postal services
because the addressee had moved or was not known at
that address (Figure 1). Males in the MD category were
more often not contactable (12.4%) compared to the
other subjects (6.6% LD males, 5% MD females and 2.4%
LD females).
GPs removed 103 subjects from the sample as they felt
that the subjects were not able to complete the study
(house bound, too ill to participate, terminal illness or lit-
eracy problems). Eighty-three were from the MD subjects
(35 females and 48 males) and 20 were from the LD sub-
jects (15 females and 5 males).
Response
The number of letters sent in each of the 12 groups to
recruit a target of 60 subjects was varied according to the
group's response rate (Table 2). The highest number of let-
ters (361) was sent to 35–44 year old males in the MD
group (response rate = 14%); the fewest (119 and 122
respectively) were sent to 55–64 year old males and
females in the LD participants (response rate 52.9% and
50% respectively – Figure 2). Although the initial target
was 60 per group (720 in total), we stopped recruitment
at 700 (in line with the power calculation) due to time
constraints.
Of the 700 subjects who participated in the study only 34
(4.9%) did not complete both visits. Of these, 12 were
35–44 years old; 14 were 45–54 years and 8 were 55–64
years (Table 2).
There were 171 male and 171 female participants in the
LD group and 168 females and 156 males in the MD
group (Table 2). The response rate was 33.9% for LD and
19.0% for MD participants, and response rate by age
group was 31.7% in 35–44 year olds, 33.3% in 45–54 year
olds and 35% in 55–64 year olds.
A total of 812 subjects (Table 2) in the sample declined
(replied NO to the invitation). There were more females
who declined (LD = 38.7% and MD = 29.6%) than males
(LD = 29.6% and MD = 26.0%). In the MD group (35–44
year olds were less likely to respond than were 55–64 year
olds, but this age difference was not seen in the LD
subjects.
A total of 1,200 people in the sample did not respond to
the letter; the non-response was 52.1% for MD and 30.9%
for LD subjects. More males did not respond (LD = 37%
Table 2: Breakdown of pSoBid study subjects
Sex/Depcat Age Group Completed Visit 1 & 2 Withdrew after Visit 1 Replied 'No' Non-Respondents Sent Letters
LD Female 35–44 55 (30.4%) 2 (1%) 66 (36.5%) 58 (32.1%) 181 (100%)
LD Female 45–54 56 (31.5%) 4 (2.2%) 74 (41.6%) 44 (24.7%) 178 (100%)
LD Female 55–64 60 (49.2%) 1 (0.8%) 46 (37.7%) 15 (12.3%) 122 (100%)
LD Female Total 171 (35.6%) 7 (1.4%) 186 (38.7%) 117 (24.3%) 481 (100%)
LD Male 35–44 52 (21.6%) 2 (0.8%) 74 (30.7%) 113 (46.9%) 241 (100%)
LD Male 45–54 58 (34.7%) 1 (0.6%) 51 (30.6%) 57 (34.1%) 167 (100%)
LD Male 55–64 61 (51.2%) 2 (1.7%) 31 (26.1%) 25 (21.0%) 119 (100%)
LD Male Total 171 (32.4%) 5 (1%) 156 (29.6%) 195 (37.0%) 527 (100%)
LD Participants 342 (33.9%) 12 (1.2%) 342 (33.9%) 312 (31%) 1008 (100%)
MD Female 35–44 55 (17.3%) 6 (1.9%) 70 (22.0%) 187 (58.8%) 318 (100%)
MD Female 45–54 55 (26%) 5 (2.4%) 69 (32.7%) 82 (38.9%) 211 (100%)
MD Female 55–64 58 (27.2%) 2 (1%) 81 (38.0%) 72 (33.8%) 213 (100%)
MD Female Total 168 (22.6%) 13 (1.8%) 220 (29.6%) 341 (46.0%) 742 (100%)
MD Male 35–44 49 (13.6%) 2 (0.5%) 56 (15.5%) 254 (70.4%) 361 (100%)
MD Male 45–54 53 (16.5%) 4 (1.3%) 79 (24.6%) 185 (57.6%) 321 (100%)
MD Male 55–64 54 (19.3%) 3 (1.1%) 115 (41.0%) 108 (38.6%) 280 (100%)
MD Male Total 156 (16.2%) 9 (0.9%) 250 (26.0%) 547 (56.9%) 962 (100%)
MD Participants 324 (19.0%) 22 (1.3%) 470 (27.6%) 888 (52.1%) 1704 (100%)
GRAND TOTAL 666 (24.6%) 34 (1.3%) 812 (29.9%) 1,200 (44.2%) 2712 (100%)
LD = Least Deprived.
MD = Most Deprived
The total response rates were calculated by combining those who completed Visit 1 & 2 (column 3) with those who withdrew after Visit 1 (column 
4).Page 7 of 11
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MD = 46%). There was an age difference for both males
and females (non-response rate higher for 35–44 com-
pared to 55–64 year olds) in both MD and LD subjects.
Discussion
The study was successful in recruiting subjects of the
desired sex and age profile from the most and least
deprived areas of Glasgow. Data zones in SIMD were the
preferred choice for our sampling process because each
covers a smaller area and population (750–1,000) than
the Postcode sectors which were used in a previous, well
used deprivation classification (DEPCAT)[63]. This is
illustrated in Figure 3 which shows the Postcode sector
G15 6 (DEPCAT 6) and the same area by data zones
(SIMD quintiles 1–5). The G15 6 area has nine data zone
areas which have clear boundaries between the various
quintiles in the SIMD and consists of least and most
deprived areas. The Information Services Division (ISD)
Scotland has recommended that routine and in-depth
NHS Board level analyses from 1997 onwards use SIMD
measure of deprivation[64].
In recruiting for the present study we found similar pat-
terns of response to those observed in earlier surveys. In
the Scottish Health Survey of 2003 (SHS 2003) from the
co-operating households, response was lowest among
those aged 16–24. Among men, response was highest
among those aged 65 plus, while among women those
aged over 24 gave a consistently high response rate[65]. In
SHS 2003, men aged below 35 years were slightly under-
represented at both interview and nurse visit relative to
their proportions in the population while men aged 55
and over were slightly over-represented. Women aged
below 25 years were under-represented at both stages,
while women aged 45–74 were overrepresented[65].
The availability of the GPASS information allowed us to
examine at least some potential bias inherent in our
recruitment strategy. Of particular concern was the possi-
Map showing Postcode Sector G15 6 by DECPAT and SIMD Data ZonesFigure 3
Map showing Postcode Sector G15 6 by DECPAT and SIMD Data Zones. SIMD = Scottish Index for Multiple Depri-
vation.Page 8 of 11
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deprived' would preferentially volunteer, so minimising
potential differences between the least and most deprived
communities.
A further methodological concern was the impact on par-
ticipation of the number of questionnaires, investigations
and the prospect of having to attend two visits of 1 1/2
hours each for this study. Only 34 participants failed to
complete both visits and the full set of evaluations. Partic-
ipants stated on a feedback questionnaire that they were
highly satisfied with the study process and some saw it as
an opportunity to have a complete medical check-up
Strengths and Limitations
The study achieved its recruitment objectives in terms of
the sample size and the nature of the recruits. The depth
and range of the evaluations performed will provide
important information concerning the relationships
between deprivation, obesity, inflammation, atheroscle-
rosis and mental outlook. This will enable us to address
the hypothesis that the increased prevalence of coronary
heart disease, type 2 diabetes and negative mental outlook
in a deprived population is attributable in large part to an
increased frequency of chronic inflammation, endothelial
dysfunction and insulin resistance linked to the more
challenging social environment.
There are limitations to the design of pSoBid[66]. Since
the sample was stratified by age and sex, it is not a true
representation of the general population; further, there is
bias due to the variation in response rate. The sample was
selected from the extremes of deprivation so as to maxim-
ise any observed differences and, therefore, provides no
information about population gradients. The cross-sec-
tional nature of the study means that it will not be possi-
ble to identify causal pathways or the temporal
relationship between variables.
That said, the breadth and depth of data collected, linkage
to NHS records, and the population-based nature of pSo-
Bid make it an important resource, now and in prospect,
for building understanding about the mechanisms that
help to explain deprivation-related ill-health.
Conclusion
The multidisciplinary approach employed in this study
will enable a more holistic understanding of the diverse
characteristics of individuals who reside in affluent and
deprived communities and their influence on health and
health inequalities. This study also illustrates the willing-
ness of subjects to volunteer for a variety of investigations
involving psychological, behavioural, sociological and
medical questions and tests including blood analysis. As
in other studies it was easier to enrol females than males,
older compared to younger people, and the more affluent
participants. Linkage to medical records allowed compar-
ison of the health characteristics of participants and non-
participants, yielding an insight into aspects of volunteer
bias in studies of this type. This study also brought
together researchers/academics from diverse disciplines to
build a more sophisticated understanding of the determi-
nants of health inequalities than can be achieved through
unidisciplinary approaches. Future analyses will enable
an understanding of the relationships between the differ-
ent types of measure, and of the pathways that link pov-
erty, biology, behaviour and psychology and lead to
health inequalities.
This article has outlined the study background, design and
recruitment. The findings from this study will be pre-
sented in future articles.
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